Minarik J - Search Results

1

Outcome of patients with multiple myeloma and hypertension treated with angiotensin-I-converting enzyme inhibitors during high-dose chemotherapy.

Buchler T, Krejci M, Svobodnik A, Adam Z, Minarik J, Bacovsky J, Scudla V, Mayer J, Vorlicek J, Hajek R. Buchler T, et al. Among authors: minarik j. Hematol J. 2005;5(7):559-64. doi: 10.1038/sj.thj.6200571. Hematol J. 2005. PMID: 15692600 Clinical Trial.

2

The relationship between proliferation and apoptosis in patients with monoclonal gammopathy of undetermined significance or multiple myeloma.

Scudla V, Ordeltova M, Bacovsky J, Vytrasova M, Horak P, Minarik J. Scudla V, et al. Among authors: minarik j. Haematologica. 2005 Dec;90(12):1713-4. Haematologica. 2005. PMID: 16330455

3

Evaluation of plasma cell propidium-iodide and annexin-V indices: their relation to prognosis in multiple myeloma.

Minarík J, Scudla V, Ordeltová M, Bacovský J, Zemanová M. Minarík J, et al. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005 Dec;149(2):271-4. doi: 10.5507/bp.2005.039. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005. PMID: 16601769

4

Prognostic significance of plasma cell propidium iodide and annexin-V indices and their mutual ratio in multiple myeloma.

Scudla V, Ordeltova M, Minarik J, Dusek L, Zemanova M, Bacovsky J. Scudla V, et al. Among authors: minarik j. Neoplasma. 2006;53(3):213-8. Neoplasma. 2006. PMID: 16652190

5

[Comparison of serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and multiple myeloma].

Scudla V, Budíková M, Pika T, Minarík J, Zemanová M, Bacovský J, Heincová V; Ceská myelomová skupina. Scudla V, et al. Among authors: minarik j. Vnitr Lek. 2006 Mar;52(3):232-40. Vnitr Lek. 2006. PMID: 16722154 Czech.

6

International prognostic index (IPI)--a critical comparison with five multiple myeloma staging systems in the group of 270 patients treated by conventional chemotherapy.

Scudla V, Zemanova M, Minarik J, Bacovsky J, Ordeltova M, Indrak K, Budikova M, Dusek L, Farbiakova V. Scudla V, et al. Among authors: minarik j. Neoplasma. 2006;53(4):277-84. Neoplasma. 2006. PMID: 16830053

7

[Contribution to the evaluation of the relationship between angiogenic cytokines, selected biological parameters and prognostic factors in multiple myeloma].

Scudla V, Pika T, Budíková M, Ordeltová M, Minarík J, Zemanová M, Bacovský J, Srovnalík K; Ceská myelomová skupina. Scudla V, et al. Among authors: minarik j. Cas Lek Cesk. 2006;145(12):929-35. Cas Lek Cesk. 2006. PMID: 17323615 Czech.

8

High-dose chemotherapy followed by autologous stem cell transplantation changes prognosis of IgD multiple myeloma.

Maisnar V, Hájek R, Scudla V, Gregora E, Büchler T, Tichý M, Kotoucek P, Kafková A, Forraiová L, Minarík J, Radocha J, Bláha V, Malý J. Maisnar V, et al. Among authors: minarik j. Bone Marrow Transplant. 2008 Jan;41(1):51-4. doi: 10.1038/sj.bmt.1705881. Epub 2007 Oct 15. Bone Marrow Transplant. 2008. PMID: 17934529

9

[Assessment of plasmatic cell proliferation and apoptosis indexes in the course of multiple myeloma].

Minarík J, Scudla V, Ordeltová M, Bacovský J, Zemanová M, Pika T. Minarík J, et al. Vnitr Lek. 2008 Jan;54(1):31-5. Vnitr Lek. 2008. PMID: 18390115 Czech.

10

Low-dose thalidomide regimens in therapy of relapsed or refractory multiple myeloma.

Zemanova M, Scudla V, Adam Z, Gregora E, Pour L, Minarik J, Pavlicek P, Pika T, Bacovsky J. Zemanova M, et al. Among authors: minarik j. Neoplasma. 2008;55(4):345-9. Neoplasma. 2008. PMID: 18505347 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters